FBIO

Fortress Biotech Inc
0.942
0.0109 (1.17%)
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0109 1.17% 0.942 16:17:27
Open Price Low Price High Price Close Price Prev Close
0.9312 0.89 0.95 0.942 0.9311
more quote information »

Recent News

Date Time Source Heading
1/27/202311:58GLOBEAvenue Therapeutics Announces $3.25 Million Registered..
1/20/202316:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as..
1/10/202308:30GLOBEJourney Medical Corporation Completes Enrollment in Phase 3..
12/20/202208:30GLOBEJourney Medical Corporation Announces Positive Comparative..
12/19/202208:50EDGARInitial Statement of Beneficial Ownership (3)
12/19/202208:00GLOBEFortress Biotech Appoints Lucy Lu, M.D., to its Board of..
12/14/202208:00GLOBEUrica Therapeutics Expands Exclusive License Agreement with..
12/06/202208:30GLOBEFortress Biotech to Participate in Cantor Medical &..
12/05/202216:05GLOBEJourney Medical Corporation to Participate in Cantor Medical..
12/05/202207:32EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202216:19EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202216:15EDGARStatement of Changes in Beneficial Ownership (4)
11/14/202217:35EDGARCurrent Report Filing (8-k)
11/14/202216:34EDGARQuarterly Report (10-q)
11/14/202216:01GLOBEFortress Biotech Reports Third Quarter 2022 Financial..
11/10/202216:10GLOBEAvenue Therapeutics Reports Third Quarter 2022 Financial..
11/10/202216:01GLOBEJourney Medical Corporation Reports Third Quarter 2022..
11/08/202208:30GLOBEAvenue Therapeutics Completes the Acquisition of Baergic Bio..
11/04/202216:07EDGARCurrent Report Filing (8-k)
11/03/202208:52GLOBEJourney Medical Corporation to Announce Third Quarter 2022..
10/28/202217:03EDGARStatement of Changes in Beneficial Ownership (4)
10/28/202216:59EDGARCurrent Report Filing (8-k)
10/24/202208:01EDGARStatement of Changes in Beneficial Ownership (4)
10/21/202217:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/05/202208:30GLOBEFortress Biotech Announces Timing of Regular Monthly..
10/04/202208:30GLOBEJourney Medical Corporation to Participate in Upcoming..
10/03/202208:00GLOBEUrica Therapeutics Appoints Seasoned Biotech Executive Jay..
9/08/202208:30GLOBEFortress Biotech to Participate in the H.C. Wainwright 24th..
8/30/202208:30GLOBEJourney Medical Corporation Announces 50% Enrollment..
8/14/202208:25TRMNDawson James Remains a Buy on Fortress Biotech (FBIO)
8/11/202216:47EDGARCurrent Report Filing (8-k)
8/11/202216:30GLOBEFortress Biotech Reports Second Quarter 2022 Financial..
8/11/202216:11EDGARQuarterly Report (10-q)
8/11/202208:00GLOBEFortress Biotech Subsidiary Helocyte Announces Grant that..
8/09/202216:01GLOBEJourney Medical Corporation Reports Second Quarter 2022..
8/03/202208:00GLOBEJourney Medical Corporation to Announce Second Quarter 2022..
7/22/202216:02EDGARCurrent Report Filing (8-k)
7/22/202208:00GLOBEFortress Biotech Appoints David Jin as Chief Financial..
7/11/202216:01EDGARCurrent Report Filing (8-k)
5/31/202208:30GLOBEFortress Biotech Announces First Patient Dosed in Phase 1..
5/24/202208:30GLOBEJourney Medical Corporation Announces Settlement Agreements..
5/23/202208:30GLOBEJourney Medical Corporation to Present at the B. Riley..
5/22/202208:26TRMNFortress Biotech (FBIO) Receives a Buy from Dawson James
5/18/202208:30GLOBEFortress Biotech to Participate in Two Upcoming May 2022..
5/17/202216:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/13/202206:35TRMNH.C. Wainwright Thinks Fortress Biotech’s Stock is Going to..
5/12/202216:22EDGARQuarterly Report (10-q)
5/12/202216:01GLOBEFortress Biotech Reports First Quarter 2022 Financial..
5/10/202216:01GLOBEJourney Medical Corporation Reports First Quarter 2022..
5/03/202216:15GLOBEJourney Medical Corporation to Announce First Quarter 2022..